RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of QURE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

uniQure N.V. stock price up 1.69% on Wednesday
(Updated on Mar 27, 2024)

Sell candidate since Feb 29, 2024 Loss -5.91% PDF

The uniQure N.V. stock price gained 1.69% on the last trading day (Wednesday, 27th Mar 2024), rising from $5.32 to $5.41. During the last trading day the stock fluctuated 4.01% from a day low at $5.24 to a day high of $5.45. The price has risen in 6 of the last 10 days and is up by 5.87% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 143 thousand more shares were traded than the day before. In total, 590 thousand shares were bought and sold for approximately $3.19 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.43% during the next 3 months and, with a 90% probability hold a price between $3.82 and $5.20 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

QURE Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, March 14, 2024, and so far it has risen 12.24%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The uniQure N.V. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.55. On a fall, the stock will find some support from the short-term average at $5.27. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for uniQure N.V. stock

uniQure N.V. finds support from accumulated volume at $5.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.210 between high and low, or 4.01%. For the last week, the stock has had daily average volatility of 3.81%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (QURE) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect uniQure N.V. to open at $5.37, and during the day (based on 14 day Average True Range), to move between $5.11 and $5.71, which gives a possible trading interval of +/-$0.302 (+/-5.58%) up or down from last closing price. If uniQure N.V. takes out the full calculated possible swing range there will be an estimated 11.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.32 (1.66%) than the resistance at $5.59 (3.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is uniQure N.V. stock A Buy?

uniQure N.V. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.520 Sell Candidate Unchanged

Predicted Opening Price for uniQure N.V. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$5.37 ( 0.80%) $5.41

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for QURE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.58 3.08 %
R2 5.50 1.60 %
R1 5.45 0.682 %
Current price: 5.41
Support S1 5.29 -2.28 %
S2 5.24 -3.20 %
S3 5.16 -4.68 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.76 6.47 %
R2 5.75 6.28 %
R1 5.59 3.33 %
Current price 5.41
Support S1 5.32 -1.66%
S2 5.28 -2.40%
S3 5.17 -4.44%

FAQ

What is the symbol for uniQure N.V. Stock and on which exchange is it traded?
The symbol for uniQure N.V. is QURE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell uniQure N.V. Stock?
uniQure N.V. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy uniQure N.V. Stock?
uniQure N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy uniQure N.V. Stock.

What's the current price of uniQure N.V. Stock?
As of the end of day on the 2024-03-27, the price of an uniQure N.V. (QURE) share was $5.41.

What is the 52-week high and low for uniQure N.V. Stock?
The 52-week high for uniQure N.V. Stock is $22.48 and the 52-week low is $4.76.

What is the market capitalization of uniQure N.V. Stock?
As of the 2024-03-27, the market capitalization of uniQure N.V. is 258.805M.

When is the next earnings date for uniQure N.V.?
The upcoming earnings date for uniQure N.V. is May 14, 2024.
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT